Products

usevoiceai

The Typescript toolkit for ambitious voice AI apps

usevoiceai.dev SourceApache-2.0AI Models & Agents / Voice Agents

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
nktsg
No social account linked
Launched
12mo ago
2025-12-04 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
X accounts@ankitiscracked
  • Launched on Show HN (1 pts)Launch

    Usevoiceai – A TypeScript toolkit for ambitious voice AI apps

    Dec 4, 2025 · 12mo agoLaunch page

Open Source & Self-Hosting

GitHub · MCP / Skill
GitHub Stars
Public repo
Forks
—
License
Apache-2.0
Primary language
JavaScript

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2025-11-26

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-07-31

Key pages

Weekly snapshots
Home
usevoiceai.dev/ Snapshot 2026-11-03

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does usevoiceai get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is usevoiceai and what platforms does it support?
usevoiceai is catalogued under Voice Agents: The Typescript toolkit for ambitious voice AI apps. Supported platforms: Web.
Is usevoiceai open source?
usevoiceai has a public repository (https://github.com/ankitiscracked/usevoiceai) under the Apache-2.0 license.Source

Related products in this category

AI Models & Agents / Voice Agents

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.